Stonepine Capital Management »

Senseonics Hldgs shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Senseonics Hldgs (SENS) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Senseonics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Senseonics Hldgs held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Senseonics Hldgs by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $277k 49k 5.68

More positions owned by Stonepine Capital Management

Evolus (EOLS)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Nektar Therapeutics Com New (NKTR)
Ultragenyx Pharmaceutical (RARE)
Camp4 Therapeutics Corp Com 13469v Ab 4 Camtek Ltd Note 12/0 (CAMP)
Insmed Com Par $.01 Call Option (INSM)
Eloxx Pharmaceuticals Com New
Kazia Therapeutics Sponsored Ads (KZIA)
Medtronic SHS Call Option (MDT)
Indivior Pharmaceuticals (INDV)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Abbott Laboratories Call Option (ABT)
Satellos Bioscience (MSLE)

View all positions for Stonepine Capital Management

Top funds holding Senseonics Hldgs

Sessa Capital IM
BlackRock
Vanguard Capital Management
Avidity Partners Management
Sio Capital Management
UBS Group
Geode Capital Management
Masters Capital Mgmt
Marshall Wace
Susquehanna International
Bank of America Corporation
Charles Schwab Investment Management
Sixth Street Partners Management Company
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Senseonics Hldgs